Patients in this trial were given a high dose supplement containing lycopene, selenium and green tea catechin for six months, and showed that there were no significant difference in PSA levels between the two groups, but there was a higher incidence of prostate cancer at re-biopsy. The gene discussed is KLK3; the disease is prostate cancer.